Product Information
CEFADROXIL 250 MG/5 ML SUSP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1674 per ML under NDC 57237009701. Its NADAC has been published 594 times since Mar 18, 2015.
FDA first approved this application on Apr 25, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
57237009701
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFADROXILApproval Type
Generic (ANDA)
FDA Application
ANDA065349FDA Approved
4/25/2013
TE Code
AB
On Market Since
4/25/2013
Pharmacological Classes
Price Statistics
The NADAC for CEFADROXIL 250 MG/5 ML SUSP has been published 594 times since Mar 18, 2015, and over the history we have for it it has declined 47.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1674 per ML |
|---|---|
| All-time high | $0.3316 (Mar 15, 2017) |
| All-time low | $0.1470 (May 22, 2024) |
| 52-week high | $0.1967 |
| 52-week low | $0.1674 |
| Median price | $0.2099 |
| Average price | $0.2214 |
| Largest weekly change | +44.7% (Jan 20, 2021) |
| Weeks tracked | 594 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefadroxil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFADROXIL 250 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFADROXIL 250 MG/5 ML SUSP, manufactured by Rising Pharma Holdings Inc., is $0.1674 per ML (NDC 57237009701), effective Sep 30, 2026.
How has the price of CEFADROXIL 250 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFADROXIL 250 MG/5 ML SUSP has declined 47.4%. It has been tracked across 594 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for CEFADROXIL 250 MG/5 ML SUSP?
Since Mar 18, 2015, the NADAC for CEFADROXIL 250 MG/5 ML SUSP has ranged from a low of $0.1470 (May 22, 2024) to a high of $0.3316 (Mar 15, 2017), with a median of $0.2099 per ML.
Are there cheaper alternatives to CEFADROXIL 250 MG/5 ML SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFADROXIL 250 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFADROXIL 250 MG/5 ML SUSP?
CEFADROXIL 250 MG/5 ML SUSP (NDC 57237009701) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.